Therapeutic Vaccination for Patients With HPV16+ Cervical Intraepithelial Neoplasia (CIN2/3)

NCT00988559 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

132

Enrollment

OTHER

Sponsor class

Conditions

HPV16 Positive
Cervical Intraepithelial Neoplasia (CIN 2/3)

Interventions

BIOLOGICAL: DNA vaccination
DEVICE: Gene gun vaccine
BIOLOGICAL: intramuscular vaccination
BIOLOGICAL: intra-lesional vaccine administration
PROCEDURE: therapeutic resection of the lesion
DRUG: imiquimod

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Collaborators

[object Object]
[object Object]